Show simple item record

dc.contributor.authorEnwemeka, Chukuka S
dc.contributor.authorBaker, Terrance L
dc.contributor.authorGreiner, Jack V
dc.contributor.authorBumah, Violet V
dc.contributor.authorMasson-Meyers, Daniela S
dc.contributor.authorCastel, John Chris
dc.contributor.authorVesonder, Modesta
dc.date.accessioned2020-10-26T19:40:20Z
dc.date.available2020-10-26T19:40:20Z
dc.date.issued2020-09-08
dc.identifier.urihttp://hdl.handle.net/10713/13948
dc.description.urihttps://doi.org/10.1089/photob.2020.4901en_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert Inc.en_US
dc.relation.ispartofPhotobiomodulation, Photomedicine, and Laser Surgeryen_US
dc.subjectblue lighten_US
dc.subject.meshCOVID-19en_US
dc.subject.meshPhotochemotherapyen_US
dc.titleAntimicrobial Photodynamic Therapy as a Potential Treatment Against COVID-19: A Case for Blue Lighten_US
dc.typeArticleen_US
dc.identifier.doi10.1089/photob.2020.4901
dc.identifier.pmid32905739
dc.source.volume38
dc.source.issue10
dc.source.beginpage577
dc.source.endpage578
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record